HealthCare Global Enterprises Limited (NSE:HCG)

Market Cap	111.27B +19.4%
Revenue (ttm)	26.27B +13.7%
Net Income	227.80M -38.6%
EPS	1.57 -40.1%
Shares Out	149.30M
PE Ratio	488.44
Forward PE	68.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,624
Open	743.00
Previous Close	745.25
Day's Range	728.00 - 743.00
52-Week Range	513.30 - 804.65
Beta	-0.04
Analysts	Strong Buy
Price Target	800.60 (+9.6%)
Earnings Date	Aug 6, 2026

About NSE:HCG

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 6,736
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: HCG

Financial Performance

In fiscal year 2026, NSE:HCG's revenue was 25.45 billion, an increase of 14.51% compared to the previous year's 22.23 billion. Earnings were 137.60 million, a decrease of -69.02%.

Analyst Summary

According to 10 analysts, the average rating for HCG stock is "Strong Buy." The 12-month stock price target is ₹800.60, which is an increase of 9.60% from the latest price.

Price Target

₹800.60

(9.60% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error